CD69 and neoplasm: These findings were further supported by the Kaplan–Meier analyses, which revealed that patients with higher frequencies of CD69+CD103+CD8+ T cells in liver tissues (Figure 3A) experienced significantly improved RFS, whereas those with higher frequencies of CD69−CD4+ and CD69−CD8+ T cells in tumor tissues (Figure 3B,C) showed lower recurrence rates.